Icon (Close Menu)

Logout

Omnibalm Recognized by Chain Drug Review as Top Niche Product

2 min read

Omnibalm Daily Foot Therapy, a product of Little Rock-based Balm Innovations, has been named a "Small Chain Niche Pick" and a "Key Special Niche Product" in Chain Drug Review’s second annual Niche Products Report, the company announced Thursday.

According to a press release, the product hit shelves in Arkansas and four neighboring states less than three months ago.

In additional to Omnibalm Daily Foot Therapy, the top 10 list includes products from companies such as Bayer HealthCare, Novartis Pharmaceuticals, Shering-Plough Healthcare Products, Procter & Gamble and Unilever.

"National recognition for this product supports our strong belief in its quality and usefulness to consumers," said Lydia Carson, president and CEO of Balm Innovations.
Omnibalm Daily Foot Therapy is a cream for general and diabetic foot care. It was developed by University of Arkansas for Medical Sciences pharmaceutical researcher Bill Gurley, who also created Balm Innovations’ original cream, Omnibalm.

Omnibalm Daily Foot Therapy is the first Balm Innovations’ product available in stores outside of Arkansas. In June, the product launched in 97 USA Drug, Super D, Drug Warehouse, May’s Drug and Med-X Drug stores in Arkansas, Oklahoma, Tennessee, Mississippi and Missouri.

According to the magazine, a product must meet the following critical niche product criteria identified by Chain Drug Review to be considered for the report:

  • Provide margins of 40 – 60 percent
  • Be capable of recording sales at least one-half to one piece per month per door
  • Be frequently recommended by physicians or other health care professionals
  • Appeal to a narrow yet meaningful segment of consumer demographics
  • Provide a specific solution or benefit to an underserved consumer market
  • Substantially increase the size of the shopper’s total market basket as well as the retailer’s dollar profits.

Balm Innovations is one of 17 UAMS BioVentures startups licensed to take UAMS’ inventions from the laboratory to the marketplace. For more information on Balm Innovations or Omnibalm creams, visit www.omnibalm.com or contact Lydia Carson at (888) 577-6580.

Send this to a friend